Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9
Hida, Toyoaki, Seto, Takashi, Horinouchi, Hidehito, Maemondo, Makoto, Takeda, Masayuki, Hotta, Katsuyuki, Hirai, Fumihiko, Kim, Young Hak, Matsumoto, Shingo, Ito, Masayuki, Ayukawa, Koichi, Tokushige, Kota, Yonemura, Masataka, Mitsudomi, Testuya, Nishio, Makoto
Published in Cancer science (01.09.2018)
Published in Cancer science (01.09.2018)
Get full text
Journal Article
Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
Goto, Hideki, Makita, Shinichi, Kato, Koji, Tokushige, Kota, Fujita, Taizo, Akashi, Koichi, Izutsu, Koji, Teshima, Takanori
Published in International journal of clinical oncology (01.09.2020)
Published in International journal of clinical oncology (01.09.2020)
Get full text
Journal Article
Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
Hiramatsu, Hidefumi, Adachi, Souichi, Umeda, Katsutsugu, Kato, Itaru, Eldjerou, Lamis, Agostinho, Andrea Chassot, Natsume, Kazuto, Tokushige, Kota, Watanabe, Yoko, Grupp, Stephan A.
Published in International journal of hematology (01.02.2020)
Published in International journal of hematology (01.02.2020)
Get full text
Journal Article
Phase I study of anti‐CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B‐cell non‐Hodgkin lymphoma
Ogura, Michinori, Hatake, Kiyohiko, Ando, Kiyoshi, Tobinai, Kensei, Tokushige, Kota, Ono, Chiho, Ishibashi, Taro, Vandendries, Erik
Published in Cancer science (01.05.2012)
Published in Cancer science (01.05.2012)
Get full text
Journal Article
Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies
Minami, Hironobu, Doi, Toshihiko, Toyoda, Masanori, Imamura, Yoshinori, Kiyota, Naomi, Mitsuma, Ayako, Shimokata, Tomoya, Naito, Yoichi, Matsubara, Nobuaki, Tajima, Takeshi, Tokushige, Kota, Ishihara, Kae, Cameron, Scott, Ando, Yuichi
Published in Cancer science (01.02.2021)
Published in Cancer science (01.02.2021)
Get full text
Journal Article
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset
Kiura, Katsuyuki, Imamura, Fumio, Kagamu, Hiroshi, Matsumoto, Shingo, Hida, Toyoaki, Nakagawa, Kazuhiko, Satouchi, Miyako, Okamoto, Isamu, Takenoyama, Mitsuhiro, Fujisaka, Yasuhito, Kurata, Takayasu, Ito, Masayuki, Tokushige, Kota, Hatano, Ben, Nishio, Makoto
Published in Japanese journal of clinical oncology (01.04.2018)
Published in Japanese journal of clinical oncology (01.04.2018)
Get full text
Journal Article
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset
Hida, Toyoaki, Satouchi, Miyako, Nakagawa, Kazuhiko, Seto, Takashi, Matsumoto, Shingo, Kiura, Katsuyuki, Nokihara, Hiroshi, Murakami, Haruyasu, Tokushige, Kota, Hatano, Ben, Nishio, Makoto
Published in Japanese journal of clinical oncology (01.07.2017)
Published in Japanese journal of clinical oncology (01.07.2017)
Get full text
Journal Article
Phase II study of the safety and efficacy of temsirolimus in East Asian patients with advanced renal cell carcinoma
Sun, Yan, Rha, Sun, Lee, Se-Hoon, Guo, Jun, Ueda, Takeshi, Qin, Shukui, Naito, Seiji, Cincotta, Maria, Tokushige, Kota, Akaza, Hideyuki
Published in Japanese journal of clinical oncology (01.09.2012)
Published in Japanese journal of clinical oncology (01.09.2012)
Get full text
Journal Article
Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors
Nishio, Makoto, Murakami, Haruyasu, Horiike, Atsushi, Takahashi, Toshiaki, Hirai, Fumihiko, Suenaga, Naoko, Tajima, Takeshi, Tokushige, Kota, Ishii, Masami, Boral, Anthony, Robson, Matthew, Seto, Takashi
Published in Journal of thoracic oncology (01.07.2015)
Published in Journal of thoracic oncology (01.07.2015)
Get full text
Journal Article
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial
Fukuhara, Noriko, Kato, Koji, Goto, Hideki, Takeshi, Tajima, Kawaguchi, Mayu, Tokushige, Kota, Akashi, Koichi, Teshima, Takanori, Harigae, Hideo, Schuster, Stephen J., Thieblemont, Catherine, Dreyling, Martin, Fowler, Nathan
Published in International journal of hematology (01.02.2023)
Published in International journal of hematology (01.02.2023)
Get full text
Journal Article
Phase I study of spartalizumab (PDR001), an anti-PD1 mAb, in Japanese patients with advanced malignancies
Ando, Yuichi, Doi, Toshihiko, Mitsuma, Ayako, Mizutani, Takefumi, Toyoda, Masanori, Imamura, Yoshinori, Kiyota, Naomi, Naito, Yoichi, Matsubara, Nobuaki, Ishihara, Kae, Tajima, Takeshi, Tokushige, Kota, Cameron, Scott, Minami, Hironobu
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
O3-2-6Phase I study of spartalizumab (PDR001), an anti-PD1 mAb, in Japanese patients with advanced malignancies
Ando, Yuichi, Doi, Toshihiko, Mitsuma, Ayako, Mizutani, Takefumi, Toyoda, Masanori, Imamura, Yoshinori, Kiyota, Naomi, Naito, Yoichi, Matsubara, Nobuaki, Ishihara, Kae, Tajima, Takeshi, Tokushige, Kota, Cameron, Scott, Minami, Hironobu
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I study of anti‐ CD 22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B ‐cell non‐ H odgkin lymphoma
Ogura, Michinori, Hatake, Kiyohiko, Ando, Kiyoshi, Tobinai, Kensei, Tokushige, Kota, Ono, Chiho, Ishibashi, Taro, Vandendries, Erik
Published in Cancer science (01.05.2012)
Published in Cancer science (01.05.2012)
Get full text
Journal Article
Phase 1 Study of Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Japanese Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Hatake, Kiyohiko, Ogura, Michinori, Ando, Kiyoshi, Tokushige, Kota, Ono, Chiho, Vandendries, Erik R., Tobinai, Kensei
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article